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Abstract
Background: Daming capsule (DMC), a traditional Chinese formula, has a lipid-modulating action with reduced
adverse side effects as compared with other lipid lowering compounds. Since endothelial dysfunction often
accompanies the hyperlipidemic state, we hypothesize that DMC might restore endothelial dysfunction produced
by a high-fat (HF) diet. Importantly, we also investigate possible mechanisms involved in mediating the effects of
DMC on vascular reactivity.
Methods: Rats were divided into four groups: control, HF diet, HF mixed DMC diet, HF mixed atorvastatin (ATV)
diet. After 30 days, the thoracic cavity was exposed to remove the thoracic aorta for (i) histological examination; (ii)
measurement of endothelial nitric oxide synthase (eNOS) by western blot; and (iii) tension study of thoracic aortic
ring.
Results: HF diet induced significant attenuation in the contraction and relaxation of rat aortic rings. Treatment
with DMC significantly improved the relaxation of the aortic rings as compared with those from HF rats (P < 0.05),
which was abolished by a nonspecific NOS inhibitor L-NAME. Moreover DMC significantly restored the decrease in
eNOS expression induced by HF diet. Similar results were found in histopathologic changes. DMC failed to restore
the loss of vasocontraction of aorta explained by an impairment of ATP-sensitive K
+ channels (KATP) on the
structure and/or function. DMC exerted the same protective effect as ATV, a positive control drug, on vascular
injury produced by HF diet.
Conclusion: DMC partially protects the aorta from HF-induced endothelial dysfunction via upregulation of the
expression of eNOS.
Background
Hyperlipidemia is an important independent risk factor
for cardiovascular diseases. Hyperlipidemia is accompa-
nied by vascular disease such as: atherosclerosis, angios-
tenosis and blocking, which may induce hypertension,
cerebral apoplexy, myocardial infarction, and even sud-
den cardiac death. Accumulating evidence indicates that
ah i g h - f a td i e ti n d u c e sb o t hs y s t e m i ca n dt i s s u eo x i d a -
tive stress and the development of early vascular lesions
[1]. Impaired endothelial function, an early hallmark of
atherogenesis, was observed in rats and healthy
volunteers fed high-saturated fat and high-sucrose meals
[2,3]. Moreover, nitric oxide (NO) produced by endothe-
lium was inhibited by high-fat diet [4]. Hyperlipidemia
and oxidation of low density lipoprotein (LDL) induce
vascular smooth muscle cell growth [5] and hyperlipide-
mia may alter the vascular response to vasodilators [6].
The regulation of vascular tone is important for main-
taining adequate perfusion to critical organs and is regu-
lated by factors released from the endothelium and by
other components such as receptors, ion channels and
signaling pathways [7,8]. Therefore, it’sv a l u a b l et o
investigate the mechanisms of various compounds on
controlling vessel tone in vessel-related diseases.
Compared with Western medicine, the traditional Chi-
nese medicine formula has a prominent advantage due
to a stable curative effect with reduced toxicity. It simul-
taneously targets multiple physiological processes to
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The traditional Chinese medicine compatibility empha-
sizes j u n ,c h e n ,z u o ,s h i(monarch, minister, adjuvant
and messenger) with proper herbs and relevant dosage
to synergize the desirable effects and minimize side
effects integrally [9]. Daming capsule (DMC) was
designed and carefully formulated in accordance with
the rule of the traditional Chinese medicine theory com-
prising: Rheum Palmatu, Cassia obtusifolia L, Salvia
miltiorrhiza and Panax ginseng C.A.. Rheum Palmatu is
regarded as monarch component for its actions on pro-
moting digestion to remove food retention and improv-
ing blood circulation to dissipate blood stasis
(Pharmacopoeia of the People’s Republic of China,
2010). Cassia obtusifolia L, Salvia miltiorrhiza and
Panax ginseng C.A. are considered as minister or adju-
vant components to enhance the pharmacological func-
tions and compensate for the side effects of Rheum
Palmatu [9]. Our previous clinical study reported that
DMC had a lipid-lowering action with lower adverse
side effects and significantly decreased serum total cho-
lesterol and LDL cholesterol indicating that it might be
a good candidate for the treatment of hyperlipidemia
[10]. Further study demonstrated that DMC could
reverse the prolonged QT and PR interval and improve
heart function [9] and also restored impaired barore-
flexes in STZ-induced diabetic rats with hyperlipidemia
[11]. There is no report related to the role of DMC on
the regulation of vascular morphology or function that
is negatively impacted by hyperlipidemia. This study was
designed to investigate whether DMC has effects on vas-
cular reactivity and to test the hypothesis that DMC
may affect endothelial nitric oxide synthase (eNOS) in
endothelium and in turn contribute to the restoration of
endothelial dysfunction of aorta from rats fed a high-fat
(HF) diet.
Methods
Chemicals and herbal materials
The formula of DMC was designed by Professor Baofeng
Yang in the department of Pharmacology of Harbin Med-
ical University (Patent No.: ZL03109063.X) and produced
by Harbin Yida Ltd as reported in our previous publica-
tions [9-11]. Briefly, the plants were harvested from cor-
responding provinces and collected at appropriate
season. The grounded powders were capsulated at a ratio
of 12:12:6:1 of Rheum Palmatu, Cassia obtusifolia L, Sal-
via miltiorrhiza and Panax ginseng C.A..T h ee n t i r ep r o -
cess was supervised according to the policy of the State
Food and Drug Administration of P.R.China. Quality
control was performed by marker compound chrysopha-
nol using HPLC analysis to quantify total anthraquinones
in DMC. The content of chrysophanol was more than 1.5
mg in each capsule (300 mg) estimated from standard
calibration curve. Atorvastatin (ATV) was purchased
from Huirui Pharmaceutical Co., Ltd., China. All reagents
used in our vascular reactivity studies were purchased
from Sigma, Saint Louis, MO, USA.
Animals
Male Wistar rats (200-230 g, n =4 0 )w e r eo b t a i n e d
from the Animal Center of the 2nd Affiliated Hospital
of Harbin Medical University, China, and housed in a
room with controlled temperature of 23 ± 1°C and
humidity of 55 ± 5% under a 12 h-12 h light-dark cycle.
All experimental procedures and protocols used in this
investigation received approval by the ethic committees
of Harbin Medical University.
Establishment of HF model
The HF emulsion was prepared as previously described
[9-11]. Fat emulsion comprised lard (20%), thyreostat
(1%), cholesterol (5%), sucrose (5%), saccharu (5%) and
sodium glutamate (1%) in 20% Tween 80 and 30% (v/v)
propylene glycol. The diet was kept at 4°C before use.
Rats were randomly divided into four groups (n =1 0i n
each group) as follows: control group, HF group, HF +
DMC (100 mg/kg/d, the optimal dose from previous
study [9]) group and HF + ATV (7.2 mg/kg/d, dissolved
with 0.5% carboxymethylcellulose sodium) group. The
control group received 0.9% NaCl (10 ml/kg/d) and the
HF rats received the HF emulsion (10 ml/kg/d) by intra-
gastric administration for 30 days. DMC and ATV was
mixed in HF emulsion and administered to the rats in
DMC treated group and ATV treated group, respectively.
Vascular reactivity studies and experimental protocols
These studies were performed as previously described
[12]. Briefly, the thoracic cavity was exposed to remove
the thoracic aorta in anesthetized rats. Adherent fat and
connective tissue was cleaned from aortas which were
used for: (i) histological examination; (ii) measurement
of eNOS by western blot; and (iii) tension study of thor-
acic aortic ring. Aortas were cut into rings (2-3 mm),
mounted on a force transducer placed in an organ bath
having pH-adjusted, oxygenated Ringer’ss o l u t i o n( m M :
NaCl 118, KCl 4.7, MgSO4 0.6, KH2PO4 1.18, CaCl2 2.5,
glucose 10 and NaHCO3 27, pH 7.4) at 37°C. Rings
were initially loaded with 1.5 g tension (basal tension)
by incremental application over 30 min and then equili-
brated for an additional 30-40 min before the studies
were started. A dose-dependent constriction to pheny-
lephrine (PE) (10
-6 Mt o1 0
-5 M) followed by measure-
ment of vasorelaxation in response to acetylcholine
(ACh) (10
-5 Mt o1 0
-4 M) was examined. Aortic rings
were washed repeatedly with Ringer’s solution until tone
recovered to basal level and then treated with different
inhibitors according to protocols as follows. Reactivity
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-5 MP Ea n d1 0
-4
M ACh. Vasorelaxation to ACh was calculated as (ten-
sion PE - tension ACh)/tension PE (the percent change
in reactivity to 10
-4 M ACh after10
-5 M PE). At termina-
tion of the experiment, KCl (60 mM) was applied to
detect the non-receptor mediated response of the rings.
Tension data were relayed from the pressure transdu-
cers to a signal amplifier. BL-420E + signal analysis soft-
ware (Chengdu, China) was employed to describe the
isometric changes in force of the aortic rings.
Protocol 1: To determine the effect of K
+ channels, 4-
amionpyridine (4-AP, 3 mM, KV channel blocker), tetra-
ethylammonium (TEA, 1 mM, BKCa channel blocker) or
glyburide (GLYB, 1 μM, KATP channel blocker) were
pre-incubated for 30 min respectively before adding PE
and ACh.
Protocol 2: To determine the effect of eNOS, N
G-
Nitro-L-arginine Methyl Ester (L-NAME, 10
-4 M, a non-
specific NOS inhibitor) was pre-incubated for 30 min
before adding PE and ACh.
Histology
The thoracic aorta segments were taken and fixed in
zinc formalin for 24 to 48 h then processed using a
Sakura Tissue Tek VIP5 processor. Processing was per-
formed using 70%, 80%, 95% and 100% ethanols, xylene
and paraffin. Following processing, samples were
oriented (embedded) in paraffin and sectioned at 4 μm
using a microtome. Sections were stained with hematox-
ylin and eosin (H&E) for histological examination.
Western blot analysis
The thoracic aorta segments were homogenized in lysis
buffer (RIPA buffer 60%, SDS 40% and protease inhibi-
tor cocktail 1%) on ice, then centrifuged at 14,000 rpm
at 4°C for 30 min to remove the insoluble pellet. Protein
concentration in the supernatant was determined by the
Biorad DC Protein Assay (Biorad, Hercules, CA, USA).
Equal amounts of protein (60 μg) were loaded on 8%
SDS-PAGE gel. The lysates were resolved by electro-
phoresis (100 V for 1 h) and transferred onto nitrocellu-
lose membranes. After being blocked in 5% nonfat milk
for 2 h, the membranes were treated with primary anti-
body for rabbit anti-eNOS (sc-654, Santa cruz, CA,
USA), overnight at 4°C and washed 5 times before incu-
bating with secondary antibody (1:2000) for 1 h. Blots
were detected with the Odyssey infrared imaging system
(Licor, USA). Protein loading was confirmed using
GAPDH (1:2000, Sigma, Saint Louis, MO, USA) as an
internal control.
Statistical analysis
Data were calculated as means ± S.E.M (standard error
of the means). The changes in vasoreactivity were
expressed as the percent increase in tone from the base-
line. The differences in mean values among the experi-
mental groups were measured using two-tailed analyses
of variance (ANOVA) followed by Dunnetts’st e s t .D i f -
ferences were considered statistically significant at P <
0.05.
Results
The dose-response reactivity curves to PE and ACh in
aortic rings
In vascular reactivity studies increasing concentrations
of PE and ACh were applied to detect vascular contrac-
tion and relaxation, respectively. Aortic rings exhibited
dose-dependent contraction and relaxation to PE (10
-6
Mt o1 0
-5 M) and ACh (10
-5 Mt o1 0
-4 M), respectively
(Figure 1A, typical tracing of vascular reactivity), indicat-
ing that 10
-5 M PE and 10
-4 M ACh were maximal and
therefore these concentrations were used in the remain-
ing experiments. As shown in Figure 1B and 1C, the
vascular contraction and relaxation were significantly
attenuated in rats fed a HF diet (124.76 ± 4.6 vs. 183.66
± 7.72 in contraction, P < 0.01; 9.09 ± 1.03 vs. 26.14 ±
2.47 in relaxation, P < 0.01). Treatment with DMC did
not improve the loss of vasocontraction (132.3 ± 3.48)
but significant mitigation was seen in the relaxation of
the aortic rings from DMC treated group (18.59 ± 1.31
vs. 9.09 ± 1.03, P < 0.01). Same result was obtained
from ATV treated rats (130.45 ± 3.42 in contraction,
17.74 ± 2.2 in relaxation). Figure 1D showed the typical
tracing of vascular reactivity with KCl. A similar trend
of vasocontraction was observed if those rings exposed
to 60 mM KCl (Figure 1E).
The influence of K
+ channels on the contraction of aortic
rings
As shown in Figure 2A, pre-incubation of 4-AP, a KV
channel blocker, significantly increased contraction of
aortic rings in control rats, indicating that KV channels
were involved in the process of constriction. Similar
results were observed in HF, DMC and ATV treated
rats, suggesting KV c h a n n e l sp l a yt h es a m er o l ei na l l
groups. Pre-incubation of GLYB, a KATP channel
blocker, significantly enhanced the vasocontraction in
control rats but not in the other groups. These results
demonstrate that blockade of KATP channels affected
vasoconstriction of rats fed a HF diet. The structure
and/or function of KATP channels may thus be altered
in HF model and were not improved by the treatment
of DMC and ATV. There was no change of vasocon-
traction in all groups after pre-incubation of TEA, BKCa
channel blocker, indicating BKCa channels were not
involved in the contraction of aortic rings. The relaxa-
tion of aortic rings of four groups weren’t changed after
pre-incubation of K
+ channel blockers (Figure 2B).
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-5 M PE before and after pre-
incubation with 4-AP, 3 mM, KV channel blocker; TEA 1 mM, BKCa channel blocker and GLYB, 1 μM, KATP channel blocker respectively for 30 min.
(B) The percent change in relaxation ((tension PE - tension Ach)/tension PE) to 10
-4 M ACh after 10
-5 M PE before and after pre-incubation with
three K
+ channel blockers respectively. Data presented as mean ± S.E.M. and expressed as percentage of baseline tension. * P < 0.01 vs.
contraction value of corresponding group before pre-incubation of K
+ channel blocker, n = 8-10 rings from 5-6 rats.
Figure 1 High-fat-induced loss of vascular reactivity of aortic rings and mitigation by DMC and ATV.( A)T y p i c a lt r a c i n ga n d( B)
Representative line graph showing increased contraction and relaxation by increasing concentration of PE and ACh. (C) The percent change in
relaxation ((tension PE - tension Ach)/tension PE) to 10
-4 M ACh after10
-5 M PE. (D) Typical tracing and (E) Vascular tension to 60 mM KCl in all
groups. Data presented as mean ± S.E.M. and expressed as percentage of baseline tension. * P < 0.01 vs. control group, # P < 0.05 vs. HF, n =
16-18 rings from 6-7 rats.
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Pre-incubation with L-NAME (a non-selective NOS
inhibitor) did not alter the contraction of rings to PE
significantly in all groups (Figure 3A). After applying
ACh there was a significant attenuation of relaxation in
control (15.15 ± 2.57 vs. 26.14 ± 2.47, P < 0.01), DMC
treated rats (11.92 ± 1.25 vs. 18.59 ± 1.31, P < 0.01) and
ATV treated rats (12.55 ± 1.38 vs. 17.74 ± 2.2, P < 0.01)
but not in those fed a HF diet (8.21 ± 1.16 vs. 9.09 ±
1.03) (Figure 3B). These data supported the idea that
eNOS participated in the relaxation of aortic rings in
control, DMC and ATV treated rats. However, HF diet
affected eNOS via a certain mechanism.
Histological characters of aortas
Representative histological sections of aorta were shown
in Figure 4. Figure 4A showed the normal structure of
the control aorta. Considerable damage in endothelial
cells was noted in HF group such as disordered arrange-
ment, unclear borderline, and even partial deletion.
There was no change in the layer of smooth muscle
(Figure 4B). In DMC and ATV treated groups, these
pathological injuries in endothelial cells were recovered
to normal (Figure 4C, D).
DMC restored eNOS expression in aortic endothelial cells
attenuated by HF diet
eNOS expression was assayed by western blotting of the
aortic homogenate. As shown in Figure 5A, HF caused the
reduction of eNOS expression as observed by a weaker
signal versus control band. DMC and ATV treated group
showed more intense bands indicating increased eNOS
expression. Protein levels of GAPDH remained unaltered
demonstrating equal protein loading. A summary of these
data was presented in Figure 5B.
Discussion
The principal finding of this study was that DMC could
partially protect the aorta from HF-induced endothelial
dysfunction via upregulating the expression of eNOS.
A n dw ed i s c o v e r e dt h a tD M Cf a i l e dt oi m p r o v et h e
impairment of contraction of aorta induced by HF on
account of the change of KATP channels on structure
and/or function.
It has been recognized that vascular smooth muscle
cells contribute to the contracting function while the
endothelium modulates this contraction via the release
of relaxing factors. In this study we applied PE and ACh
to investigate the contraction and relaxation of aorta
respectively after HF diet with or without DMC and
ATV intervention. PE is a a1-adrenergic receptor ago-
nist used extensively as a vasoconstrictor [13]. ACh is
an endothelial-dependent vasodilator and a well-known
method for monitoring the status of the vascular
endothelium [14]. Our result demonstrated that HF diet
induced significant attenuation of the vasocontraction
and relaxation, indicating impaired vascular responsive-
ness and elasticity caused by the injury of smooth mus-
cle layer as well as endothelium, which was consistent
with those previously shown [1-3,6]. Treatment with
Figure 3 Effect of eNOS on the relaxation of aortic rings.( A) The contraction of aortic rings with 10
-5 M PE before and after pre-incubation
of L-NAME, 10
-4 M, eNOS inhibitor. (B) The percent change in relaxation (tension PE - tension ACh/tension PE) to 10
-4 M ACh after 10
-5 MP E
before and after pre-incubation of L-NAME. Data presented as mean ± S.E.M. and expressed as percentage of baseline tension. * P < 0.01 vs.
relaxation value of corresponding group before pre-incubation of L-NAME, n = 8-10 rings from 5-6 rats.
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cle cells but it restored vascular endothelial dilation
function. NO, as the most important endogenous vaso-
dilator agent, is generated by the catalysis of L-arginine
by eNOS which is a critical regulator of vascular tone
[15]. Therefore, it is necessary to investigate the func-
tion of eNOS in aortas of different groups. Employment
of a non-specific NOS inhibitor (L-NAME) indicated
the participation of eNOS in vasorelaxation in DMC
treated group as well as control rats. However HF diet
impacted the function of eNOS via a certain mechanism
therefore resulted in the abolishment of relaxation.
Further evidence was obtained by the expression of
eNOS in western blot analysis. Treatment with DMC
recovered the decrease of eNOS expression induced by
HF diet. We infer that the activity and expression of
eNOS were involved in the mechanism of DMC for
mitigation. Similar results were found in histopathologic
examination with endothelial damage in HF rats. This
pathologic damage was not found in rats with DMC
treatment. Therefore we conclude that DMC protected,
at least in part, the endothelial dysfunction of aorta in
high-fat diet rats. Lipid-modulating drugs statins (HMG-
CoA reductase inhibitors) are a milestone to lower cho-
lesterol levels in blood and become one of the most
powerful pharmacological strategies in the treatment of
cardiovascular diseases [16]. Statins could relax vascular
tone importantly by endothelium-dependent pathway
[17]. It exerts cholesterol-independent vasoprotective
effects by upregulating endothelial nitric oxide synthase
and decreasing superoxide production [18]. In this study
atorvastatin (ATV) was applied as a positive control to
DMC. Our results were consistent with these previous
reports and ATV has the same protective effect on
endothelial dysfunction as DMC.
K
+ channels play an important role in the regulation
of vascular function through inflowing or outflowing K
+
and Ca
2+ current. There are at least four different
classes of K
+ channels, including inward rectifier K
+
channels (KIR), ATP-sensitive K
+ channels (KATP), vol-
tage-gated K
+ channels (KV), and large conductance Ca
2
+-activated K
+ channels (BKCa). It was proposed that
blockade of KATP,K V,a n dB K Ca, which lead to mem-
brane depolarization, the activation of Ca
2+ channels, an
increased Ca
2+ influx, and vasoconstriction ensues
[19-21]. In this study, K
+ channel blockers including 4-
AP, GLYB, TEA for KV,K ATP,a n dB K Ca respectively
were employed to determine the contribution of particu-
lar K
+ channels in vascular tone of aortic rings. The
results revealed that BKCa channel were not involved in
the contraction of aortic rings and KV channels were
involved in this process but played the same role in all
groups, indicating that the mechanism of the attenua-
tion of aortic contraction in HF and DMC and ATV
treated rats was not relevant to BKCa and KV channels.
The blockade of KATP channel significantly enhanced
Figure 4 Representative sections (4 μmt h i c k )o fH & Es t a i n e d
of thoracic aorta.( A) Control rats. (B) HF rats, with considerable
damage in endothelial cells including disorder arrangement, unclear
borderline and partial deletion (arrow). (C) HF + DMC rats, with less
injury than observed in HF rats. (D) HF + ATV rats, with less injury
than observed in HF rats. Scale bars represent 200 μm.
Figure 5 High-fat-induced attenuation of eNOS protein
expression in thoracic aorta and mitigation by DMC and ATV.
(A) Representative examples of western blot assay of eNOS (140
kDa) protein are shown including GADPH expression (45 kDa) as a
loading control. (B) Statistical bar graph indicates the result of
densitometric analysis of the bands as normalized to the quantity of
GADPH protein. These ratios were normalized to control. * P < 0.01
vs. control group, # P < 0.05 vs. HF, n =4 .
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not in the other groups. The results demonstrated that
in normal condition KATP channels participated in the
constriction process of aorta, but their structure and/or
function were altered in HF model and these alterations
were not mitigated by the treatment of DMC and ATV.
Fan LH et al. [22] proved that HF diet may impair the
function and expression of KATP channels in vascular
smooth muscle cells by patch clamp and western blot-
ting, which provides powerful evidence for our results.
So we proposed that the impairment of KATP channels
might be the mechanism that DMC and ATV cannot
restore the dysfunction of contraction of aorta induced
by HF. Though it has been reported that pravastatin has
a significant beneficial effect during myocardial ische-
mia, which is provided by KATP channels and NO [23],
our results did not show the restoration of ATV on
KATP channels impaired by HF model.
DMC abides by j u n ,c h e n ,z u o ,s h i(monarch, minister,
adjuvant and messenger) and a holistic concept of tradi-
tional Chinese medicine formula and is good at treating
chronic diseases due to reduced adverse side effects even
for long-term application. Here we didn’ti n v e s t i g a t e
each component of DMC separately because it destructed
the drug interactions. Despite of a compound the quality
of DMC can be controlled accurately. Chrysophanol, the
criteria of quality control of Rheum Palmatu which is the
potent component of DMC, is applied to control the sta-
bility of the formula (Pharmacopoeia of the People’s
Republic of China, 2010). The location and season of
plant acquisition and preparation process of DMC were
controlled strictly for quality assurance. DMC is a
research project having independent intellectual property
rights and has been applied extensively in Chinese clinic
as a lipid modulating drug for ten years. DMC protects
heart function in streptozocin-induced diabetic rats with
hyperlipidemia [9]. Our research found the protection of
DMC on vascular injury induced by HF diet and provided
a powerful evidence for expanding the clinical application
of DMC particularly in patients with diabetes mellitus
accompanied by hyperlipidemia. Moreover our study dis-
c l o s e dt h es a m ep r o t e c t i v ee f f e c to fD M Ca n dA T Vo n
vascular endothelial dysfunction produced by HF diet.
Therefore, DMC displays remarkable advantages with
lower adverse side effects and provides a new candidate
for prevention and therapy of vascular injury induced by
hyperlipdiemia.
In our study, we did not obtain the restoration of
DMC on the impairment of contraction of aorta. Maybe
DMC treatment for a longer period would present an
effect with more intensity in vascular reactivity. Further-
more, peripheric arteries such as tail artery and mesen-
teric artery could present a different effect. Definitely all
these need to be further investigated. More importantly,
many studies indicated that inducible nitric oxide
synthase (iNOS) was relevant to vascular injury [24-26]
and oxidative stress induced the expression of iNOS and
subsequent generation of high concentration of NO,
which could interact with reactive oxygen species (ROS)
causing vascular dysfunction [26-28]. The effect of DMC
on ROS and iNOS in the process of vasomotion will be
elucidated by our future studies.
Conclusions
The present findings provided the first effort to establish
that DMC could partially protect the endothelial dys-
function of aorta in HF diet rats via upregulating the
expression of eNOS.
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